InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: cheynew post# 279585

Saturday, 06/16/2018 8:15:18 AM

Saturday, June 16, 2018 8:15:18 AM

Post# of 345597

HS-110/Nivolumab Combination



Well the Biomarkers pulled here just may prove my theory
viagenpumatucel-l HS-110
Vaccine derived from irradiated human lung cancer cells genetically engineered to continually secrete gp96-Ig

https://www.smartpatients.com/trials/NCT02439450

PI said "just need some improvement"


...I say some know that the Biomarker data proves the improvement came with PS Targeting IP

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News